151 related articles for article (PubMed ID: 20039457)
21. MSH3 expression does not influence the sensitivity of colon cancer HCT116 cell line to oxaliplatin and poly(ADP-ribose) polymerase (PARP) inhibitor as monotherapy or in combination.
Tentori L; Muzi A; Dorio AS; Dolci S; Campolo F; Vernole P; Lacal PM; Praz F; Graziani G
Cancer Chemother Pharmacol; 2013 Jul; 72(1):117-25. PubMed ID: 23636450
[TBL] [Abstract][Full Text] [Related]
22. Reactive oxygen species mediate oxaliplatin-induced epithelial-mesenchymal transition and invasive potential in colon cancer.
Jiao L; Li DD; Yang CL; Peng RQ; Guo YQ; Zhang XS; Zhu XF
Tumour Biol; 2016 Jun; 37(6):8413-23. PubMed ID: 26733168
[TBL] [Abstract][Full Text] [Related]
23. β-Cryptoxanthin Synergistically Enhances the Antitumoral Activity of Oxaliplatin through ΔNP73 Negative Regulation in Colon Cancer.
San Millán C; Soldevilla B; Martín P; Gil-Calderón B; Compte M; Pérez-Sacristán B; Donoso E; Peña C; Romero J; Granado-Lorencio F; Bonilla F; Domínguez G
Clin Cancer Res; 2015 Oct; 21(19):4398-409. PubMed ID: 26023082
[TBL] [Abstract][Full Text] [Related]
24. Oxaliplatin-mediated inhibition of survivin increases sensitivity of head and neck squamous cell carcinoma cell lines to paclitaxel.
Khan Z; Khan N; Varma AK; Tiwari RP; Mouhamad S; Prasad GB; Bisen P
Curr Cancer Drug Targets; 2010 Nov; 10(7):660-9. PubMed ID: 20578991
[TBL] [Abstract][Full Text] [Related]
25. Down-regulation of thymidylate synthase expression and its steady-state mRNA by oxaliplatin in colon cancer cells.
Yeh KH; Cheng AL; Wan JP; Lin CS; Liu CC
Anticancer Drugs; 2004 Apr; 15(4):371-6. PubMed ID: 15057142
[TBL] [Abstract][Full Text] [Related]
26. [Roles of hMMS2 gene in reversing the oxaliplatin tolerance of human colon carcinoma cells].
Zhang L; Sui Y; Wang T; Li L; Li Y; Jin C; Xu F
Yi Chuan; 2014 Apr; 36(4):346-53. PubMed ID: 24846979
[TBL] [Abstract][Full Text] [Related]
27. FAP-1 association with Fas (Apo-1) inhibits Fas expression on the cell surface.
Ivanov VN; Lopez Bergami P; Maulit G; Sato TA; Sassoon D; Ronai Z
Mol Cell Biol; 2003 May; 23(10):3623-35. PubMed ID: 12724420
[TBL] [Abstract][Full Text] [Related]
28. Magnetic gold nanoparticle-mediated small interference RNA silencing Bag-1 gene for colon cancer therapy.
Huang W; Liu Z; Zhou G; Tian A; Sun N
Oncol Rep; 2016 Feb; 35(2):978-84. PubMed ID: 26717967
[TBL] [Abstract][Full Text] [Related]
29. miR-506 enhances the sensitivity of human colorectal cancer cells to oxaliplatin by suppressing MDR1/P-gp expression.
Zhou H; Lin C; Zhang Y; Zhang X; Zhang C; Zhang P; Xie X; Ren Z
Cell Prolif; 2017 Jun; 50(3):. PubMed ID: 28217977
[TBL] [Abstract][Full Text] [Related]
30. Oxaliplatin, a potent inhibitor of survivin, enhances paclitaxel-induced apoptosis and mitotic catastrophe in colon cancer cells.
Fujie Y; Yamamoto H; Ngan CY; Takagi A; Hayashi T; Suzuki R; Ezumi K; Takemasa I; Ikeda M; Sekimoto M; Matsuura N; Monden M
Jpn J Clin Oncol; 2005 Aug; 35(8):453-63. PubMed ID: 16024531
[TBL] [Abstract][Full Text] [Related]
31. The role of Her2-Nrf2 axis in induction of oxaliplatin resistance in colon cancer cells.
Pirpour Tazehkand A; Akbarzadeh M; Velaie K; Sadeghi MR; Samadi N
Biomed Pharmacother; 2018 Jul; 103():755-766. PubMed ID: 29684854
[TBL] [Abstract][Full Text] [Related]
32. [Impact of biological function on ovarian clear cell carcinoma ES2 cell line with ARID1A gene expression down-regulating in vitro].
Lyu CS; Zhang YL; Lang JH
Zhonghua Fu Chan Ke Za Zhi; 2016 Mar; 51(3):209-15. PubMed ID: 27030501
[TBL] [Abstract][Full Text] [Related]
33. Adeno-associated virus-mediated survivin mutant Thr34Ala cooperates with oxaliplatin to inhibit tumor growth and angiogenesis in colon cancer.
Xue Z; Sun PH; Zhu LM; Jiang SH; Qiao MM; Chi AL; Tu SP
Oncol Rep; 2011 Apr; 25(4):1039-46. PubMed ID: 21279308
[TBL] [Abstract][Full Text] [Related]
34. A study of the suppressive effect on human pancreatic adenocarcinoma cell proliferation and angiogenesis by stable plasmid-based siRNA silencing of c-Src gene expression.
Zhao X; Li DC; Zhao H; Li Z; Wang JX; Zhu DM; Zhou J; Cen JN
Oncol Rep; 2012 Mar; 27(3):628-36. PubMed ID: 22200682
[TBL] [Abstract][Full Text] [Related]
35. The COX-2 selective inhibitor-independent COX-2 effect on colon carcinoma cells is associated with the Delta1/Notch1 pathway.
Zhang H; Ye Y; Bai Z; Wang S
Dig Dis Sci; 2008 Aug; 53(8):2195-203. PubMed ID: 18320325
[TBL] [Abstract][Full Text] [Related]
36. FAS associated phosphatase (FAP-1) blocks apoptosis of astrocytomas through dephosphorylation of FAS.
Foehr ED; Lorente G; Vincent V; Nikolich K; Urfer R
J Neurooncol; 2005 Sep; 74(3):241-8. PubMed ID: 16187021
[TBL] [Abstract][Full Text] [Related]
37. SW480 colorectal cancer cells that naturally express Lgr5 are more sensitive to the most common chemotherapeutic agents than Lgr5-negative SW480 cells.
Planutis AK; Holcombe RF; Planoutene MV; Planoutis KS
Anticancer Drugs; 2015 Oct; 26(9):942-7. PubMed ID: 26196680
[TBL] [Abstract][Full Text] [Related]
38. Safety and Efficacy of Oxaliplatin Doublet Adjuvant Chemotherapy in Elderly Patients With Stage III Colon Cancer.
Brungs D; Aghmesheh M; de Souza P; Carolan M; Clingan P; Rose J; Ranson M
Clin Colorectal Cancer; 2018 Sep; 17(3):e549-e555. PubMed ID: 29861156
[TBL] [Abstract][Full Text] [Related]
39. Establishment and gene analysis of an oxaliplatin-resistant colon cancer cell line THC8307/L-OHP.
Tang H; Liu YJ; Liu M; Li X
Anticancer Drugs; 2007 Jul; 18(6):633-9. PubMed ID: 17762391
[TBL] [Abstract][Full Text] [Related]
40. [Impact of the biological function on epithelial ovarian cancer with ITIH4 gene expression down-regulating in vitro].
Huang M; Wang Q; Zhang W; Li DR; Li L
Zhonghua Fu Chan Ke Za Zhi; 2013 Jan; 48(1):34-40. PubMed ID: 23531249
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
